Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

8 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Eligibility Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers and Squamous Cell Carcinoma of the Head and Neck NCT01059643

- 03.09.18 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT01059643 Sponsor: Eli Lilly and Company Information provided by (Responsible Party): Eli Lilly and Company

Eligibility DRKS00005561 NCT00508664 Squamous Cell Carcinoma of the Hypopharynx - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00508664

dbGaP phs000716 GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia - Eligibility

- 14.12.22 - 5 Formulare, 1 Itemgruppe, 3 Datenelemente, 1 Sprache
Itemgruppe: IG.elig
Principal Investigator: Qing Lan, MD, PhD, MPH, National Institutes of Health, Bethesda, MD, USA MeSH: Lung Neoplasms,Adenocarcinoma,Squamous Cell Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000716 To learn about the etiology of lung cancer among never-smoking women in Asia, we formed the Female Lung Cancer Consortium in Asia (FLCCA), which includes studies of lung cancer in Eastern Asia and conducted a GWAS. We analyzed a total of 5510 lung cancer cases and 4544 controls and identified 3 novel loci (Lan et al., 2012). Of these study subjects, 4922 lung cancer cases and 3959 controls are available for posting. Lan et al.., Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012 Dec;44(12):1330-5. doi: 10.1038/ng.2456. Epub 2012 Nov 11. PubMed PMID: 23143601.

pht003705.v1.p1

1 Itemgruppe 3 Datenelemente

pht003706.v1.p1

1 Itemgruppe 2 Datenelemente

pht003708.v1.p1

1 Itemgruppe 4 Datenelemente

pht003707.v1.p1

1 Itemgruppe 7 Datenelemente

Eligibility Head and Neck Squamous Cell Carcinomas (HNSCCs) NCT02025062

- 16.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02025062

Eligibility Squamous Cell Carcinoma of the Head and Neck NCT01528163

- 17.09.21 - 1 Formular, 2 Itemgruppen, 26 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT01528163

Eligibility Head and Neck Squamous Cell Carcinoma NCT02143622

- 18.10.15 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02143622

Eligibility Carcinoma of Unknown Primary NCT00388024

- 25.01.17 - 1 Formular, 1 Itemgruppe, 18 Datenelemente, 1 Sprache
Itemgruppe: Criteria
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00388024

Eligibility Squamous Cell Carcinoma of the Head and Neck NCT02454179

- 30.06.21 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02454179

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video